Laporan Laba Rugi (TTM)
Laporan Laba Rugi XTL Biopharmaceuticals Ltd. - Depositary Receipt (Common Stock) menunjukkan perubahan pendapatan dan pengeluaran selama periode waktu tertentu. Data Laporan Laba Rugi meliputi Penjualan dan Pendapatan, Laba Kotor, Penelitian dan Pengembangan (R&D), Beban Penjualan, Umum dan Administrasi (SG&A), Laba Operasi, Beban Pajak Penghasilan, Beban Bunga, Pendapatan Non-Operasi, Laba per Saham (EPS), dan Saham yang Beredar.
Semua angka adalah kelipatan 1,000,000 kecuali unit per saham.
|
2024 09-30 |
2024 12-31 |
|
|---|---|---|
| Revenue | 0 | 0 |
| Change (%) | 880.43 | |
| % of Revenue | 100.00 | 100.00 |
| Cost Of Sales | 0 | |
| Change (%) | ||
| % of Revenue | 99.33 | |
| Gross Operating Profit | 0 | 0 |
| Change (%) | -93.48 | |
| % of Revenue | 100.00 | 0.67 |
| SG&A | 2 | 2 |
| Change (%) | 35.40 | |
| % of Revenue | 3,334.78 | 460.53 |
| R&D | 0 | 0 |
| Change (%) | 36.11 | |
| % of Revenue | 156.52 | 21.73 |
| OpEx | 2 | 3 |
| Change (%) | 63.33 | |
| % of Revenue | 3,491.30 | 581.60 |
| Operating Income | -2 | -2 |
| Change (%) | 39.23 | |
| % of Revenue | -3,391.30 | -481.60 |
| Interest Expense | -0 | -0 |
| Change (%) | -24.32 | |
| % of Revenue | -80.43 | -6.21 |
| Net Income | -1 | -1 |
| Change (%) | -2.75 | |
| % of Revenue | -2,295.65 | -227.72 |
Source: Capital IQ
